Less is more? De-intensification of therapy for early-stage HER2-positive breast cancer
Lancet Oncol
.
2017 Apr;18(4):428-429.
doi: 10.1016/S1470-2045(17)30150-X.
Epub 2017 Feb 24.
Authors
Aju Mathew
1
,
Adam Brufsky
2
Affiliations
1
University of Kentucky Markey Cancer Center, Lexington, KY, USA.
2
Magee-Womens Hospital of the University of Pittsburgh Medical Center, Pittsburgh, PA 15241, USA. Electronic address: brufskyam@upmc.edu.
PMID:
28238596
DOI:
10.1016/S1470-2045(17)30150-X
No abstract available
Publication types
Comment
MeSH terms
Breast Neoplasms*
Humans
Receptor, ErbB-2*
Substances
Receptor, ErbB-2